摘要
目的评估黄芪注射液治疗肺心病的临床疗效。方法将128例肺心病患者随机分为治疗组和对照组,两组均给予抗感染,祛痰,平喘,强心,利尿等综合治疗,治疗组在此基础上给予黄芪注射液,每日1次,10d为1个疗程。结果治疗组治疗后CO、CI、LVEF与治疗前相比,均有明显改善(P<0.05);对照组治疗后CI及LVEF与治疗前相比,亦有显著改善(P<0.05)。比较治疗组与对照组的心功能参数指标,除HR外,其余指数差异均有统计学意义(P<0.05);同时,治疗组患者经治疗后PaO2、PaCO2与对照组患者相比,差异均有统计学意义(P<0.05);比较治疗组治疗后与治疗前各血液流变学指标,差异有统计学意义(P<0.05),且治疗组治疗后的血液流变学指标与对照组治疗后各指标相比,差异有统计学意义(P<0.05)。结论黄芪注射液能有效矫正肺心病患者心肺功能,保护心肌,改善血气分析指数,改善血液流变学指标,在抗感染、祛痰、平喘治疗基础上加以辅助使用可取得满意的临床疗效,值得推广。
Objective To analyze the clinical effect of astragalus injection in treating pulmonary heart disease. Methods 128 cases of patients with pulmonary heart disease were randomly divided into treatment group and control group. They were also given anti-inflammatory, expectorant, anti-asthma, strong heart, diuresis therapy. Besides,the treatment group were also given astragalus injection. Results After treatment, the treatment group of CO, CI, LVEF were obviously improved （P〈0.05） ; the control group of CI and LVEF also improved significantly （ P〈0.05 ）. Compare with the control group, the treatment group of heart function parameters except HR were significant （ P〈0.05 ）; At the same time, compared with the contrd group,PaO2, PaCO2 of the treatment group after treatment, the differences was significant （P〈0.05）; before and after treatment, the blood rheology indexes of the treatment group was significantly different（P〈0.05 ）, and compared to control group , the differences was also significantly different （P〈0. 05）. Conclusion The astragalus injection in treating pulmonary heart disease treatment of pulmonary heart disease can effectively improve respiratory function, correction of heart and lung function, reliable curative effect. It is worthy of popularization and application.
出处
《成都医学院学报》
CAS
2013年第3期343-345,共3页
Journal of Chengdu Medical College
关键词
黄芪注射液
肺心病
临床疗效
Astragalus injection
Pulmonary heart disease
Clinical effect
